Active targeting of HER2-positive breast cancer cells by Herceptin-functionalized organically modified silica

Vahid Shirshahi1, Fereshteh Shamsipour2, Amir Hassan Zarnani3

  • 1Department of Medical Nanotechnology, School of Advanced Medical Technologies, Tehran University of Medical Sciences, Tehran, Iran.

Cancer Nanotechnology
|June 13, 2015
PubMed